Assessment of fetal and neonatal outcomes in the off spring of women who had been treated with dried ginger (Zingiberis rhizoma siccus) for a variety of illnesses during pregnancy

Journal of Obstetrics and Gynaecology

Volumn 35, Issue 2, 2015, Pages 125-130

  Choi, J S ^a   Han, J Y ^a   Ahn, H K ^a   Lee, S W ^a   Koong, M K ^a   Velazquez Armenta, E Y ^b   Nava Ocampo, A A ^b,c  

^a Catholic Kwandong University   (South Korea)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Epidemiological studies; Fetal development; Maternal fetal relations

Indexed keywords

HERBACEOUS AGENT; PLANT MEDICINAL PRODUCT;

ADULT; ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; FEMALE; FETUS OUTCOME; GESTATIONAL AGE; GINGER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; STILLBIRTH; CASE REPORT; CONGENITAL ABNORMALITIES; DIGESTIVE SYSTEM DISEASES; EPIDEMIOLOGY; INCIDENCE; PHYTOTHERAPY; PREGNANCY COMPLICATIONS; SOUTH KOREA;

ADULT; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONGENITAL ABNORMALITIES; DIGESTIVE SYSTEM DISEASES; FEMALE; GINGER; HUMANS; INCIDENCE; MALE; PHYTOTHERAPY; PLANT PREPARATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; REPUBLIC OF KOREA; STILLBIRTH;

EID: 84921024456     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2014.941342     Document Type: Article

References (19)

1. Chrubasik S, Pittler MH, Roufogalis BD. 2005. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 12:684-701.
2. Cousens S, Blencowe H, Stanton C, Chou D, Ahmed S, Steinhardt L et al. 2011. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet 377:1319-1330.
3. Evira Finnish Food Safety Authority. 2010. Warning label to be added on food supplements containing ginger as well as on ginger tea, and corresponding drink powders. Available at: www.evira.fi/portal/en/food/manufacture-and-sales/labelling/warning-labelling-and-instructions-for-use/warning-label-to-be-added-on-food-supplements-containing-ginger-as-well-as-on-ginger-tea-and-corresponding-drink-powders(Accessed 31 October 2013).
4. Heitmann K, Nordeng H, Holst L. 2013. Safety of ginger use in pregnancy: results from a large population-based cohort study. European Journal of Clinical Pharmacology 69:269-277.
5. Kim HC. 2001. Hanyak yangnihak. 1st ed. [in Korean]. Seoul: Chimmundang.
6. KIMS. Zingiberis rhizoma. Seoul. Available at: www.kimsonline.co.kr/ (Accessed 31 October 2013).
7. Nordeng H, Havnen GC. 2004. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiology and Drug Safety 13:371-380.
8. Nuttall GA, Brost BC, Connis RT, Gessner JS, Harrison CR, Miller RD et al. 2006. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105:198-208.
9. Pongrojpaw D, Somprasit C, Chanthasenanont A. 2007. A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy. Journal of the Medical Association of Thailand 90:1703-1709.
10. Portnoi G, Chng LA, Karimi-Tabesh L, Koren G, Tan MP, Einarson A. 2003. Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. American Journal of Obstetrics and Gynecology 189:1374-1377 [Erratum in: Journal of Obstetrics and Gynecology 2004; 190:1140].
11. Tiran D. 2012. Ginger to reduce nausea and vomiting during pregnancy: evidence of effectiveness is not the same as proof of safety. Complementary Therapies in Clinical Practice 18:2-25.
12. Traditional Oriental Medicine Data Base (Tradimed). Zingiberis rhizoma siccus. Seoul. Available at: www.tradimed.co.kr (Accessed 31 October 2013).
13. Weidner MS, Sigwart K. 2001. Investigation of the teratogenic potential of a Zingiber officinale extract in the rat. Reproductive Toxicology 15:75-80.
14. White B. 2007. Ginger: an overview. American Family Physician 75:1689-1691.
15. Wilkinson JM. 2000. Effect of ginger tea on the fetal development of Sprague-Dawley rats. Reproductive Toxicology 14:507-512.
16. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical classification system. Oslo, Norway: Norwegian Institute of Public Health. Available at: www.whocc.no/atc (Accessed 31 October 2013).
17. World Medical Association. 2008. Declaration of Helsinki - Ethical principles for medical research involving human subjects. 59th WMA General Assembly, Seoul, Korea. Available at: www.wma.net/en/30publications/10policies/b3 (Accessed 31 October 2013).
18. Yang JH, Kim YJ, Chung JH, Kim MY, Ryu HM, Ahn HK et al. 2004. A multicenter study for birth defect monitoring systems in Korea. Journal of Korean medical science 19:509-513.
19. Yook JH, Han JY, Choi JS, Ahn HK, Lee SW, Kim MY et al. 2012. Pregnancy outcomes and factors associated with voluntary termination in women who had been treated for acne with isotretinoin. Clinical Toxicology 50:896-901.